- Home
- / LiNA Medical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
LiNA Medical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
KR240 M
FY, 2022
CreditSafe Score
?
Score changed on Jun 14, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| DKK | FY, 2020 | FY, 2021 | FY, 2022 |
|---|---|---|---|
| Revenue | 241.1M | 233.5M | 240.0M |
| Cost of goods sold | 191.0M | 194.7M | 204.1M |
| Gross profit | 50.1M | 38.9M | 35.8M |
| Gross profit margin, % | 20.8% | 16.6% | 14.9% |
| General and administrative expense | 25.9M | 26.8M | 31.8M |
| Operating expense total | 27.6M | 28.0M | 33.7M |
| EBIT | 22.4M | 10.9M | 2.1M |
| EBIT margin, % | 9.3% | 4.7% | 0.9% |
| Interest income | 6.9M | 7.6M | 5.6M |
| Interest expense | 2.8M | 4.1M | 7.0M |
| Pre tax profit | 26.5M | 14.5M | 645.6K |
| Income tax expense | 5.8M | 3.2M | 154.6K |
| Net Income | 20.7M | 11.3M | 490.9K |